Vesiculobullous Lesions
Oral Pathology · Core Clinical Science
TL;DR
Vesiculobullous lesions are fluid-filled blisters of the oral mucosa that rupture rapidly, leaving painful erosions or ulcers. The critical clinical challenge is separating life-threatening autoimmune blistering diseases — pemphigus vulgaris and mucous membrane pemphigoid — from infectious and reactive causes, as treatment is radically different.
- The level of blister formation (intraepithelial vs. subepithelial) determines both the histological appearance and the fragility of the blister roof — intraepithelial blisters rupture almost instantly in the mouth, while subepithelial blisters are more intact.
- Pemphigus vulgaris: IgG against desmoglein 3; suprabasal acantholysis; fishnet DIF pattern; high mortality if untreated — treat with systemic corticosteroids ± rituximab.
- Mucous membrane pemphigoid: IgG/IgA against basement membrane (BP180/BP230); subepithelial split; linear basement membrane DIF; desquamative gingivitis is the classic oral presentation; ocular involvement can cause blindness — urgent ophthalmology referral.
- Primary herpetic gingivostomatitis (HSV-1): diffuse vesicles on all oral mucosal surfaces including keratinised mucosa; fever, lymphadenopathy; aciclovir within 72 hours of onset.
- Erythema multiforme: target lesions on skin + haemorrhagic lip crusting + oral erosions; most commonly triggered by HSV or drugs; Stevens-Johnson syndrome is severe mucocutaneous involvement.
Key Facts
What Are Vesiculobullous Lesions?
A vesicle is a small fluid-filled blister (under 1 cm); a bulla is a larger blister (over 1 cm). In the oral cavity, both rupture rapidly due to the constant mechanical trauma of mastication, speech, and tongue movement, leaving erosions or ulcers that can be indistinguishable from other erosive conditions at the time of presentation. Clinicians must therefore think of vesiculobullous disease even when presenting lesions appear purely ulcerative.
The aetiology is broad: autoimmune diseases in which the immune system attacks structural proteins of the epithelium or basement membrane; viral infections producing intracellular cytopathic vesicles; and hypersensitivity reactions causing epidermal necrosis. Because treatments differ so dramatically — immunosuppression for autoimmune disease versus antivirals for herpetic disease, with immunosuppression potentially worsening an undiagnosed infection — accurate diagnosis is paramount.
Blister Formation Mechanisms
The location of the split within the epithelium determines the structural integrity of the blister roof and the pattern seen on light microscopy and immunofluorescence.
Intraepithelial Blisters
When the split occurs within the epithelium, the blister roof consists only of superficial epithelial layers and is extremely fragile — it collapses almost immediately under the mechanical forces of the oral environment. These blisters are rarely seen intact clinically; the patient presents with raw, painful erosions. The underlying mechanisms include loss of desmosomes (acantholysis, as in pemphigus) or viral cytopathic damage to individual keratinocytes (as in herpes). On histology, free-floating, rounded acantholytic epithelial cells (Tzanck cells) are a hallmark of pemphigus.
Subepithelial Blisters
When the split occurs below the epithelium, at or beneath the basement membrane, the entire intact epithelium forms the blister roof, making these bullae mechanically more robust. They may be seen clinically as intact tense blisters before rupturing. The target antigens are components of the hemidesmosome-anchoring fibril complex (BP180, BP230, laminin-332, collagen VII). Mucous membrane pemphigoid is the prototypical subepithelial blistering disease of the oral cavity.
Immune-Mediated Vesiculobullous Conditions
Pemphigus Vulgaris
Pemphigus vulgaris (PV) is an autoimmune intraepithelial blistering disease caused by IgG autoantibodies directed against desmoglein 3 (Dsg3), a transmembrane glycoprotein component of desmosomes. Loss of desmosomal adhesion leads to acantholysis — separation of keratinocytes from one another — producing a suprabasal split. The basal cells remain attached to the basement membrane, creating the classic “tombstone” appearance (a row of intact basal cells with separated spinous-layer cells above).
The oral cavity is involved in over 90% of cases and is frequently the first site of disease — often predating skin lesions by months to years. Clinically, PV produces irregular, ragged, painful erosions that heal poorly without treatment. A positive Nikolsky’s sign (the epithelium slides laterally with gentle pressure, revealing a moist, glistening surface) is characteristic but not specific. The diagnosis is confirmed by DIF showing intercellular IgG deposition in a fishnet/chicken-wire pattern throughout the epithelium.
Before systemic corticosteroids were available, the mortality of PV was approximately 75%. Treatment is systemic prednisolone with steroid-sparing agents (azathioprine, mycophenolate mofetil); rituximab (anti-CD20 monoclonal antibody) is now recommended as first-line or steroid-sparing therapy in moderate-to-severe disease, having dramatically improved outcomes.
Mucous Membrane Pemphigoid (MMP)
Mucous membrane pemphigoid (formerly cicatricial pemphigoid) is an autoimmune subepithelial blistering disease in which IgG and/or IgA autoantibodies target components of the epithelial basement membrane zone — most commonly BP180 (type XVII collagen) and BP230. The subepithelial split produces a more intact blister roof than pemphigus, though these blisters still rupture and heal with scarring (cicatrisation) — the key distinguishing feature from most other vesiculobullous diseases.
The most common oral presentation is desquamative gingivitis — erythematous, eroded, peeling gingiva that is intensely sensitive and bleeds easily. DIF shows a linear band of IgG (and/or IgA and C3) along the basement membrane. The diagnosis must prompt assessment of all other mucosal surfaces. Ocular involvement (conjunctival MMP) causes progressive scarring, symblepharon formation, and eventually blindness — warranting urgent ophthalmology referral. Genital, oesophageal, nasal, and laryngeal mucosae may also be affected.
Treatment for localised oral MMP includes topical corticosteroids (clobetasol gel) and chlorhexidine; widespread or ocular disease requires systemic dapsone, tetracyclines, or immunosuppressants.
Linear IgA Disease
Linear IgA disease is a rare autoimmune subepithelial blistering disorder characterised by linear deposition of IgA (not IgG) at the basement membrane on DIF. It can be idiopathic or drug-induced (notably by vancomycin). Oral lesions resemble MMP. Treatment is dapsone; drug-induced cases resolve on withdrawal of the causative agent.
Epidermolysis Bullosa (EB)
Epidermolysis bullosa is a heterogeneous group of inherited mechanobullous diseases in which genetic mutations in structural proteins of the dermal-epidermal junction produce extreme fragility of skin and mucous membranes. Blisters form spontaneously or with minimal trauma. The dystrophic form (collagen VII mutation) causes severe oral involvement with blistering, microstomia from scarring, ankyloglossia, and a markedly increased risk of squamous cell carcinoma in chronically scarred tissue. Dental management requires atraumatic technique, lubrication of all instruments and appliances, and specialist coordination.
Infectious Vesicular Lesions
Primary Herpetic Gingivostomatitis
Primary infection with herpes simplex virus type 1 (HSV-1) most commonly occurs in young children (6 months–5 years) and young adults. The virus is acquired from an infected individual shedding virus asymptomatically. After an incubation period of 2–12 days, the illness presents with a prodrome of fever, malaise, irritability, and cervical lymphadenopathy, followed by eruption of multiple small vesicles on all oral mucosal surfaces — including keratinised (hard palate, gingiva, dorsal tongue) and non-keratinised mucosa alike. The vesicles rupture rapidly to form painful, shallow ulcers with a grey-yellow base and erythematous halo.
The gingivae are typically intensely inflamed (herpetic gingivitis), and the child may refuse to eat or drink, risking dehydration. Treatment within 72 hours of onset with oral aciclovir (or valaciclovir in adults) reduces severity and duration. Supportive care includes hydration, analgesics, and chlorhexidine rinse. The virus establishes latency in the trigeminal ganglion and may reactivate as recurrent herpes labialis throughout life.
Recurrent Herpes Simplex (Intraoral)
Recurrent intraoral herpes occurs on keratinised, firmly bound mucosa only — the hard palate and attached gingiva. This distribution is a crucial distinguishing feature from recurrent aphthous stomatitis (RAS), which exclusively affects non-keratinised mucosa. Lesions present as a cluster of small vesicles that rupture to form small pinpoint ulcers, often preceded by a prodrome of tingling or burning. Triggers include local trauma, dental procedures, UV exposure, stress, and immunosuppression. Antiviral therapy is effective if started during the prodrome.
Hand, Foot and Mouth Disease
Hand, foot and mouth disease (HFMD) is caused by Coxsackievirus A16 (most common) and Enterovirus 71, members of the Picornaviridae family. It is predominantly a disease of children under 10. Oral lesions consist of vesicles and ulcers on the tongue, buccal mucosa, and palate, accompanied by vesicular lesions on the palms, soles, and sometimes the buttocks. Fever and malaise are present. The condition is self-limiting, typically resolving within 7–10 days. No specific antiviral treatment is available; management is supportive.
Herpangina
Herpangina is caused by Coxsackievirus A (types 1–6, 8, 10, 22) and presents with sudden onset fever, sore throat, and vesicles and ulcers confined to the posterior oral cavity — soft palate, anterior fauces, and uvula. The anterior oral cavity is spared, distinguishing it from primary herpetic gingivostomatitis. It occurs in children and resolves spontaneously within 1 week. Treatment is supportive.
Erythema Multiforme
Erythema multiforme (EM) is an acute, immune-mediated mucocutaneous condition most often triggered by herpes simplex virus infection (~70% of recurrent cases) or drugs (sulfonamides, NSAIDs, anticonvulsants). It is not a primary vesiculobullous disease but causes widespread epithelial necrosis and blister formation.
Oral lesions are extensive, painful erosions affecting any mucosal surface, often with haemorrhagic crusting of the lips — a highly characteristic sign. Skin lesions are the classic target (iris) lesions — concentric rings of erythema, oedema, and central crusting or bullae on the extremities and trunk. Minor EM has limited skin and mucosal involvement; Stevens-Johnson syndrome (SJS) involves extensive mucocutaneous necrosis affecting ≥2 mucosal surfaces with <10% body surface area skin detachment; toxic epidermal necrolysis (TEN) involves >30% body surface area and carries a mortality rate of 25–35%.
Management of EM includes identification and elimination of the trigger (antiviral suppressive therapy with aciclovir for recurrent HSV-triggered EM), topical corticosteroids for oral lesions, and systemic corticosteroids for severe cases. SJS/TEN requires urgent hospitalisation, multidisciplinary management, and wound care in a burns unit.
Vesiculobullous Disease Comparison
The following table summarises the key differentiating features of the major vesiculobullous conditions.
| Condition | Aetiology / Antigen | Blister Level | DIF Pattern | Key Clinical Feature | Treatment |
|---|---|---|---|---|---|
| Pemphigus Vulgaris | IgG anti-desmoglein 3 | Intraepithelial (suprabasal) | Intercellular fishnet IgG | Nikolsky’s sign; oral first | Prednisolone + rituximab |
| Mucous Membrane Pemphigoid | IgG/IgA anti-BP180/BP230 | Subepithelial | Linear BM IgG/IgA/C3 | Desquamative gingivitis; ocular scarring | Topical/systemic steroids; dapsone |
| Linear IgA Disease | IgA anti-BM zone | Subepithelial | Linear BM IgA | May be drug-induced (vancomycin) | Dapsone; remove causative drug |
| Primary HSV | HSV-1 viral infection | Intraepithelial (viral CPE) | N/A | All mucosal surfaces; fever; child/young adult | Aciclovir within 72 h |
| Herpangina | Coxsackievirus A | Intraepithelial | N/A | Posterior oral cavity only; children | Supportive |
| Erythema Multiforme | HSV/drug hypersensitivity | Epidermal necrosis | Non-specific | Target lesions; haemorrhagic lip crusting | Treat trigger; systemic steroids |
Clinical Considerations
- Always consider DIF before treating presumed “ulcers”: Any persistent, widespread, or desquamative oral erosion in an adult that does not have an obvious cause should be biopsied with DIF as a priority investigation. The window for DIF closes once treatment is started.
- Screen all MMP patients for ocular involvement: Referral to ophthalmology is mandatory for all patients with confirmed or suspected MMP. Conjunctival involvement can be asymptomatic until irreversible scarring has occurred. Delay in ophthalmological assessment risks blindness.
- Differentiate primary from recurrent HSV by site: Primary HSV involves all mucosal surfaces including gingiva and hard palate; recurrent intraoral HSV is confined to keratinised mucosa (hard palate, attached gingiva). Recurrent HSV on non-keratinised mucosa does not occur — those lesions are aphthae or MMP until proven otherwise.
- Nikolsky’s sign is not pathognomonic for pemphigus: It is positive in MMP, TEN, and other blistering diseases. Its value is in confirming epithelial fragility, not in making a specific diagnosis. DIF is the gold standard.
- Epidermolysis bullosa requires specialist dental planning: Any dental procedure, including rubber dam and impressions, can induce new blisters. Use of lubricants, soft impressions materials, and atraumatic techniques is essential. These patients should be managed in specialist centres.
Common Mistakes & Misconceptions
-
Misconception: “The absence of intact blisters rules out pemphigus vulgaris.”
Correction: Intraepithelial blisters rupture almost instantly in the oral environment. Pemphigus typically presents as ragged erosions, not blisters. Clinical suspicion must remain high even when only erosions are visible. -
Misconception: “Desquamative gingivitis is always caused by poor oral hygiene.”
Correction: Desquamative gingivitis is a clinical descriptor — not a diagnosis — and is the most common oral presentation of MMP, pemphigus, and erosive lichen planus. It requires biopsy and DIF for definitive diagnosis. Treating it as gingivitis without investigation is a significant management error. -
Misconception: “Herpangina and primary herpetic gingivostomatitis are both caused by HSV.”
Correction: Herpangina is caused by Coxsackievirus (enterovirus), not HSV. Primary herpetic gingivostomatitis is caused by HSV-1. The distinction matters because aciclovir is ineffective against Coxsackievirus. -
Misconception: “Erythema multiforme is a mild skin rash with some oral sores.”
Correction: The EM spectrum includes Stevens-Johnson syndrome and toxic epidermal necrolysis, which are life-threatening emergencies with significant mortality. Drug-triggered SJS/TEN must be recognised early and managed in a hospital setting. -
Misconception: “MMP and pemphigus are treated the same way.”
Correction: While both require immunosuppression, MMP can often be controlled with topical corticosteroids for oral disease alone, whereas pemphigus vulgaris routinely requires systemic immunosuppression and increasingly rituximab. Dapsone is useful in MMP and linear IgA disease but not typically in pemphigus.
Related Topics
Vesiculobullous lesions have significant overlap with other categories of oral pathology and systemic medicine.
References & Sources
- Neville BW, Damm DD, Allen CM, Chi AC (2015). Oral and Maxillofacial Pathology, 4th ed. Elsevier Saunders.
- Scully C, Mignogna M (2008). “Oral mucosal disease: pemphigus.” British Journal of Oral and Maxillofacial Surgery, 46(4):272–277.
- Rashid H, Gürcan HM, Ahmed AR (2006). “Antigen specificity in subsets of mucous membrane pemphigoid.” Journal of Investigative Dermatology, 126(12):2631–2636.
- Regezi JA, Sciubba JJ, Jordan RCK (2017). Oral Pathology: Clinical Pathologic Correlations, 7th ed. Elsevier.
- Joly P et al. (2017). “First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus.” Lancet, 389(10083):2031–2040.
- Bastuji-Garin S et al. (1993). “SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.” Journal of Investigative Dermatology, 115(2):149–153.
Summary
Vesiculobullous lesions of the oral cavity are among the most diagnostically challenging conditions in oral medicine. The key to correct management lies in understanding blister-level anatomy: intraepithelial blisters (pemphigus vulgaris, viral disease) rupture immediately and present as erosions; subepithelial blisters (MMP, linear IgA disease) are more intact and scar on healing. Direct immunofluorescence on perilesional tissue is the gold-standard investigation for the autoimmune blistering diseases and must always be performed on fresh tissue in Michel’s medium. The infectious vesicular lesions — primary HSV, herpangina, HFMD — are distinguished by distribution, patient age, systemic features, and viral serology. Erythema multiforme can mimic autoimmune disease; identifying the trigger (usually HSV or a drug) and excluding SJS/TEN are the clinical priorities.
Key Takeaways
- Pemphigus vulgaris (IgG anti-Dsg3): Suprabasal acantholysis; fishnet DIF; Nikolsky’s sign; oral lesions precede skin; rituximab + steroids.
- MMP (IgG/IgA anti-BP180): Subepithelial split; linear BM DIF; desquamative gingivitis; ocular involvement → blindness — urgent ophthalmology referral mandatory.
- Primary HSV: All mucosal surfaces including keratinised; fever + lymphadenopathy; aciclovir within 72 h; recurrent intraoral HSV affects keratinised mucosa only.
- Herpangina vs. HFMD: Herpangina = posterior oral cavity (Coxsackievirus A); HFMD = anterior oral + palmar-plantar rash (Coxsackievirus A16); neither responds to aciclovir.
- Erythema multiforme: HSV-triggered most commonly; target skin lesions + haemorrhagic lip crusting; SJS/TEN = life-threatening spectrum requiring hospitalisation.
About the Author
